Global Barium Sulfate Suspension Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Barium Sulfate Suspension Market Research Report 2024
Barium sulfate suspension, often simply called barium, is a contrast agent used during X-rays. Specifically it is used to improve visualization of the gastrointestinal tract (esophagus, stomach, intestines) on plain X-ray or computed tomography. It is taken by mouth or used rectally. Side effects include constipation, diarrhea, appendicitis, and if inhaled inflammation of the lungs. It is not recommended in people with intestinal perforation or bowel obstruction. Allergic reactions are rare. The use of barium during pregnancy is safe for the baby; however, X-rays may result in harm. Barium sulfate suspension is typically made by mixing barium sulfate powder with water. It is a non-iodinated contrast media.
According to Mr Accuracy reports’s new survey, global Barium Sulfate Suspension market is projected to reach US$ 367.1 million in 2029, increasing from US$ 232 million in 2022, with the CAGR of 6.4% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Barium Sulfate Suspension market research.
Key manufacturers engaged in the Barium Sulfate Suspension industry include Bracco Diagnostics, Genus Medical, Mallinckrodt, SaintroyLifescience, EZ-EM Canada Inc, Sinopharm Shantou Jinshi Pharmaceutical Co., Ltd., Xi'an Disai Biological Pharmaceutical Co., Ltd. and Qingdao Red Butterfly Precision Materials Co., Ltd., etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Barium Sulfate Suspension were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Barium Sulfate Suspension market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Barium Sulfate Suspension market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Bracco Diagnostics
Genus Medical
Mallinckrodt
SaintroyLifescience
EZ-EM Canada Inc
Sinopharm Shantou Jinshi Pharmaceutical Co., Ltd.
Xi'an Disai Biological Pharmaceutical Co., Ltd.
Qingdao Red Butterfly Precision Materials Co., Ltd.
Segment by Type
Low Density
Medium Density
High Density
Hospital
Clinic
Diagnostic Center
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Barium Sulfate Suspension report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Barium Sulfate Suspension market is projected to reach US$ 367.1 million in 2029, increasing from US$ 232 million in 2022, with the CAGR of 6.4% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Barium Sulfate Suspension market research.
Key manufacturers engaged in the Barium Sulfate Suspension industry include Bracco Diagnostics, Genus Medical, Mallinckrodt, SaintroyLifescience, EZ-EM Canada Inc, Sinopharm Shantou Jinshi Pharmaceutical Co., Ltd., Xi'an Disai Biological Pharmaceutical Co., Ltd. and Qingdao Red Butterfly Precision Materials Co., Ltd., etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Barium Sulfate Suspension were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Barium Sulfate Suspension market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Barium Sulfate Suspension market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company
Bracco Diagnostics
Genus Medical
Mallinckrodt
SaintroyLifescience
EZ-EM Canada Inc
Sinopharm Shantou Jinshi Pharmaceutical Co., Ltd.
Xi'an Disai Biological Pharmaceutical Co., Ltd.
Qingdao Red Butterfly Precision Materials Co., Ltd.
Segment by Type
Low Density
Medium Density
High Density
Segment by Application
Hospital
Clinic
Diagnostic Center
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Barium Sulfate Suspension report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
